Abstract:Objective:To observe the effects of transurethral split of the prostate (TUSP) on the urodynamics, the sexual function and the quality of life of benign prostatic hyperplasia.Methods:Eighty patients with benign prostatic hyperplasia admitted to the Deqing People′s Hospital of Zhejiang Province from January 2017 to June 2019 were enrolled into the research objects prospectively. According to the random digits table method, they were divided into group A and group B, with 40 cases in each group. The group A was treated with TUSP, while the group B was treated with bipolar transurethral plasma kinetic prostatectomy (TUPKP). The operation time, intraoperative blood loss, bladder irrigation time, urinary catheter indwelling time, hospitalization time of the two groups were compared and surgical effects were evaluated. The changes of hemoglobin (Hb), serum sodium (Na), post-void residual volume (PVR), maximum urinary flow rate (Q max), international prostate symptom score (IPSS) and international index of erectile function score (IIEF-5), the quality of life index (QOL) of 2 groups before and after the operation were measured. Surgical complications were recorded. Results:The operation time, bladder irrigation time, urinary catheter indwelling time and hospital stay in group A were all shorter than that in group B: (15.63 ± 4.17) min vs. (58.79 ± 10.45) min, (6.26 ± 1.17) h vs. (45.51 ± 10.03) h, (3.07 ± 0.68) d vs. (5.67 ± 1.51) d, (3.63 ± 0.43) d vs. (6.08 ± 1.72) d, (18.32 ± 2.79) ml vs. (65.26 ± 20.64) ml, and there were statistical differences ( P<0.05); there were no statistical difference between 2 groups in surgical curative effect grade and Na 1 d after operation ( P>0.05); 1 day after operation, Hb in group A was higher than that in group B: (115.63 ± 9.78) g/L vs. (109.65 ± 8.36) g/L, and there was statistical difference ( P<0.05); PVR, Q max, IPSS, IIEF-5 and QOL 3 and 6 months after surgery were improved in 2 groups ( P<0.05), but the difference between 2 groups was not statistically significant ( P>0.05); the total complication rate in group A was lower than that in group B: 10.00% (4/40) vs. 27.50% (11/40), and there was statistical difference ( P<0.05). Conclusions:TUSP and TUPKP are equally effective in the treatment of benign prostatic hyperplasia, both of which can improve the symptoms of prostatic hyperplasia, improve the quality of life and improve sexual function. But TUSP has less intraoperative bleeding, shorter operation time, faster postoperative recovery, fewer complications, and higher safety.

The Comparion of the Clinical Efficacy Between 1470 Nm Diode Laser and Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

The Diagnostic Value of Prostate Cancer Between Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Retrospective Comparative Study

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

1.9Μm-Vela XL Laser Vaporization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: Randomized Controlled Study

Short-term Effect of 980/1470nm Diode Laser Technology on Benign Prostatic Hyperplasia

Transurethral domestic 1470 nm laser vaporization for the treatment of <30 g small-volume benign prostatic hyperplasia

Different Lasers in the Treatment of Benign Prostatic Hyperplasia: a Network Meta-Analysis.

A Comparative Study of Transurethral Plasmakinetic Resection Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

Technique and efficacy of 1470 nm diode laser antegradeenucleation of the prostate for benign Prostatic hyperplasia

Clinical Study of Efficacy and Safety of Transurethral Photoselective Laser Vaporization for Benign Prostatic Hyperplasia

Clinical Comparative Study of Transurethral Electroresection and Transurethral Electrovaporization in Bening Prostatic Hyperplasia

Comparison Between Thulium Laser Resection of Prostate and Transurethral Plasmakinetic Resection of Prostate or Transurethral Resection of Prostate

A clinic comparative study of transurethral bipolar vaporizations and TURP for the treatment of BPH

A Comparative Study of Thulium Laser Resection of the Prostate and Bipolar Transurethral Plasmakinetic Prostatectomy for Treating Benign Prostatic Hyperplasia.

GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial.

Comparative Study of the Clinical Efficacy of Transurethral Enucleation of the Prostate and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia

Randomized controlled trial comparing between 1 470 nm diode laser enucleation of the prostate and plasmakinetic enucleation of the prostate for treating benign prostatic hyperplasia

Clinical Comparison of Transurethral Enucleation and Resection of Prostate for Treatment of Benign Prostatic Hyperplasia with Monopolar Resectoscope

Comparison of 532-nm GreenLight HPS laser with 980-nm diode laser vaporization of the prostate in treating patients with lower urinary tract symptom secondary to benign prostatic hyperplasia: a meta-analysis

Comparison of Diode Laser (980 nm) Enucleation vs Holmium Laser Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Randomized Controlled Trial with 12-Month Follow-Up